AusBiotech has announced the appointment of a new CEO to succeed the retiring Glenn Cross.
The association's chair Julie Phillips has just . announced the elevation of current deputy CEO Lorraine Chiroiu at the AusMedtech dinner in Adelaide tonight.
Ms Chiroiu, who has worked at AusBiotech for almost ten years, will succeed Mr Cross who has been with the association for 13 years and spent the past two years as CEO.
AusBiotech announced Mr Cross will transition to a part-time contract role leading a dedicated business development effort for AusEvents.
Ms Chiroiu has previously held the roles of chief industry affairs officer and national communications and media manager at AusBiotech. Before joining the association, she worked in corporate and public affairs roles for a multinational biopharmaceutical company, the Pharmacy Guild of Australia, the University of Melbourne and a health consumer organisation.
Ms Phillips said: “Ms Chiroiu is well known to members and has achieved a great deal to date. We are fortunate to have such a depth of talent and experience in our organisation, and the Board is delighted to welcome Lorraine to her new Chief Executive role in the organisation.”
“I feel truly privileged by the opportunity to lead AusBiotech into its next phase of growth and evolution," said Ms Chiroiu. "Together we can support the expansion and prosperity of the Australian life sciences industry, a significant economic and social contributor with a proud history and which is well positioned to build on its success for many years to come."
Ms Chiroiu thanked the Board and acknowledged Mr Cross for his contribution to AusBiotech. "When I think about our industry, as innovators, we have the perseverance, commitment and passion required to drive the development process - the development process that changes lives. I look forward to continuing to work with all of you."